Raytelligence AB: Raytelligence mission from Stemtech Corporation continues
Raytelligence's assignment from Stemtech Corporation continues. The assignment includes advice on a reverse takeover of Stemtech Corporation by a company traded on a Nordic marketplace.
On 12 December, the Board of Directors of Spotlight-traded Eevia Health Plc announced that it had decided to terminate the process of a reverse takeover of Stemtech. Raytelligence acted as advisor in this process. Raytelligence's assignment continues and is focused on identifying other possible candidates.
Stemtech Corporation and Seacret Direct, LLC (renamed `VIÁGO') reached an agreement on 20 November 2024 on a strategic merger. In connection with this agreement, Raytelligence announced that it had received an assignment from Stemtech regarding advice in connection with the reverse acquisition of a company whose shares are traded on a marketplace in the Nordic region.
Raytelligence's remuneration is mainly paid in shares in the event of a successfully completed transaction and in the event that the transaction is not completed, no consulting fee is paid.
Driving innovation and market expansion:
Stemtech Corporation: Stemtech and VIÁGO offer a strong combination of stem cell-based supplements and a diverse customer offering in lifestyle and wellness that includes travel, health, beauty and events. The company has over 250,000 members, customers and independent representatives and operates in over 40 countries, in North and South America, Asia, Africa and Europe..
For further information, please contact:
Ben Hedenberg, CFO, Raytelligence AB
E-mail: ben.hedenberg@raytelligence.com
Phone: +46 (0)8-551 160 90 / +44 7944 316 906
Briefly about Raytelligence
Raytelligence is an investment company whose key strategy is to identify and complete combination deals with businesses in any of the following sectors biotechnology & pharmaceuticals, automotive, financial services, communications technology, food technology, cutting edge technologies and media sectors in Europe, America and Asia that can benefit from our management team's extensive experience and operational capability, although the company reserves the right to exercise an acquisition option in any company or industry. Raytelligence is listed on NGM Nordic SME.